LEADER 01277nam  2200289z- 450 
001 9910689430103321
005 20161209100704.0
035   $a(CKB)5860000000032233
035   $a(BIP)008702730
035   $a(EXLCZ)995860000000032233
100   $a20220406c2001uuuu  -u-         -
101 0 $aeng
200 10$aRecent developments which may impact consumer access to, and demand for, pharmaceuticals $ehearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 13, 2001
215   $a1 online resource (iii, 235 p.) 
311   $a0-16-066171-4 
517   $aRecent developments which may impact consumer access to, and demand for, pharmaceuticals 
606   $aPharmaceutical policy$zUnited States
606   $aDrug accessibility$zUnited States
610   $aPharmaceutical policy
610   $aPolitical science
615  0$aPharmaceutical policy
615  0$aDrug accessibility
712 02$aUnited States, Congress House Committee on Energy and Commerce Subcommittee on Health Staff,$4oth
906   $aBOOK
912   $a9910689430103321
996   $aRecent developments which may impact consumer access to, and demand for, pharmaceuticals$93138532
997   $aUNINA